Data / Form D filings / SynGen Inc.
SynGen Inc.: Form D filings
SynGen Inc., a biotechnology company in Sacramento, CA, filed 15 Form D notices with the SEC between 2012 and 2017. The latest, on June 26, 2017, reports $400,000 sold of a $400,000 offering to 1 investor.
Find out what SynGen Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 HOWE AVENUE, SUITE 185N, Sacramento, CA, 95825
- Phone
- (916) 706-0923
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1547876
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 26, 2017 | New notice | $400,000 | $400,000 | $0 | 1 | Jun 14, 2017 | sec.gov |
| Apr 21, 2017 | New notice | $500,000 | $500,000 | $0 | 1 | Apr 18, 2017 | sec.gov |
| Mar 24, 2017 | New notice | $500,000 | $500,000 | $0 | 1 | Mar 21, 2017 | sec.gov |
| Feb 27, 2017 | New notice | $500,000 | $500,000 | $0 | 2 | Feb 21, 2017 | sec.gov |
| Jan 19, 2017 | New notice | $500,000 | $500,000 | $0 | 2 | Jan 12, 2017 | sec.gov |
| Nov 28, 2016 | New notice | $1,000,000 | $1,000,000 | $0 | 3 | Nov 14, 2016 | sec.gov |
| Jul 26, 2016 | New notice | $2,000,000 | $1,000,000 | $1,000,000 | 3 | Jul 13, 2016 | sec.gov |
| May 10, 2016 | New notice | $1,563,422 | $1,563,422 | $0 | 3 | Apr 26, 2016 | sec.gov |
| Feb 10, 2016 | New notice | $2,000,000 | $2,000,000 | $0 | 2 | Jan 8, 2016 | sec.gov |
| Jun 8, 2015 | New notice | $3,000,000 | $2,250,000 | $750,000 | 2 | Mar 25, 2015 | sec.gov |
| Sep 22, 2014 | New notice | $4,000,000 | $2,000,000 | $2,000,000 | 2 | Sep 12, 2014 | sec.gov |
| Jan 7, 2014 | New notice | Indefinite | $0 | Indefinite | 1 | Dec 27, 2013 | sec.gov |
| Jul 10, 2013 | New notice | $3,000,000 | $1,000,000 | $2,000,000 | 2 | Jul 2, 2013 | sec.gov |
| Jul 10, 2013 | Amendment | $5,000,000 | $2,000,000 | $3,000,000 | 2 | Apr 17, 2012 | sec.gov |
| Apr 24, 2012 | New notice | $5,000,000 | $2,000,000 | $3,000,000 | 2 | Apr 17, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Vic H. Schmitt | Director | |
| Philip H. Coelho | Executive Officer | |
| Chuck A. Novak | Executive Officer | |
| George H. Barry | Director | |
| Carl A. Goldfischer | Director | |
| William H. Gerber | Executive Officer, Director | |
| Woodrow A. Myers, Jr. | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of Jun 26, 2017 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SynGen Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.